Search

everythinglearnresearchcommunity

for

Search:↓

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Porphyra-334 may help reduce wrinkles and promote hair growth.

CLEC10A and interleukin-42 can help identify PCOS patients' response to Metformin treatment.

Chromosomal differences affect how muscle cells respond to testosterone.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

Most children treated with diphencyprone regrew some or all of their hair.

WNT10B affects hair growth by altering gene activity in hair cells.

L-Selectin and adiponectin can help identify PCOS patients who respond to Metformin treatment.

Most patients with alopecia areata see significant hair regrowth within 93 days of starting ritlecitinib treatment.

Genetic variations may affect how well finasteride works for BPH patients.

JAK inhibitors improve hair growth in alopecia areata, especially in patchy types.

Sonidegib is effective and safe for treating advanced basal cell carcinoma, but biopsies are needed to confirm tumor clearance.

The patient with lupus and Degos' disease showed significant improvement with treatment.

Taking finasteride every other month can still help with hair loss but may be less effective over time compared to taking it daily.

Cross-section trichometry is an accurate method to measure hair loss and growth.

Injecting any solution helps acne scars, and ultrasound is useful for checking treatment results.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

New treatments for alopecia areata may target specific immune cells and pathways involved in hair loss.

COVID-19 may cause common hair loss due to stress, immune response, medications, and other health issues.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Individualized assessment and meticulous planning are crucial for successful brow and upper eyelid surgery.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Alopecia treatment should use a modern, combined approach to effectively address hair loss.

Genetic factors could lead to personalized treatments for hair loss.

NSG mice had the most mites, and genetic factors affect immune response and susceptibility.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Modern treatments can effectively regrow hair and improve life for people with alopecia areata.

Quercetin effectively treated and prevented hair loss in mice.